Effects of pituitary adenylate cyclase activating polypeptide27 on cyclic AMP efflux and atrial dynamics in perfused beating atria

European Journal of Pharmacology

Volumn 402, Issue 1-2, 2000, Pages 129-137

  Cui, Xun ^a   Lee, Sook Jeong ^a   Kim, Sung Zoo ^a   Kim, Suhn Hee ^a   Cho, Kyung Woo ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Atrium; cAMP; Pituitary adenylate cyclase activating polypeptide (PACAP)

Indexed keywords

CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ATRIUM CONTRACTION; HEART BEAT; HEART MUSCLE CONTRACTILE FORCE; HEART PERFUSION; HEART RATE; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT;

1-METHYL-3-ISOBUTYLXANTHINE; ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; HEART; HEART ATRIA; ISOPROTERENOL; MYOCARDIUM; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PHOSPHODIESTERASE INHIBITORS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RABBITS; RADIOIMMUNOASSAY; STROKE VOLUME;

EID: 0343962181     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00514-8     Document Type: Article

References (20)

1. Ascuitto R.J., Ross-Ascuitto N.T., Waddell A.E., Kadowitz P.J. Contractile and coronary vascular effects of pituitary adenylate cyclase activating polypeptide in neonatal pig hearts. Cardiovasc. Res. 31:1996;E153-E159.
2. Arimura A., Somogyvari-Vigh A., Miyata A., Mizuno K., Coy D.H., Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology. 129:1991;2787-2789.
3. Cho K.W., Kim S.H., Hwang Y.H., Seul K.H. Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion. J. Physiol. 468:1993;591-607.
4. Cho K.W., Kim S.H., Kim C.H., Seul K.H. Mechanical basis of atrial natriuretic peptide secretion in beating atria: atrial stroke volume and ECF translocation. Am. J. Physiol. 268:1995;R1129-R1136.
5. Florio C., Frausin F., Vertua R., Gaion R.M. Involvement of P1 receptors in the effect of forskolin on cyclic AMP accumulation and export in PC12 cells. Biochem. Pharmacol. 57:1999;355-364.
6. Hirose M., Furukawa Y., Nagashima Y., Lakhe M., Miyashita Y., Chiba S. PACAP-27 causes negative and positive dromotropic effects in anesthetized dogs. Eur. J. Pharmacol. 338:1997;35-42.
7. Inagaki N., Yoshida H., Mizuta M., Mizuno N., Fujii Y., Gonoi T., Miyazaki J.I., Seino S. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. U. S. A. 91:1994;2679-2683.
8. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
9. Johnson R.R., Farbman A.I., Gonzales F. The effect of cAMP on nuritic outgrowth in explant cultures of developing chick olfactory epithelium. J. Neurobiol. 19:1988;681-693.
10. Mi Z., Jackson E.K. Metabolism of exogenous cAMP to adenosine in the rat kidney. J. Pharmacol. Exp. Ther. 273:1995;728-733.
11. Miyata Y., Arimura K., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:1989;567-574.
12. Miyata A., Jiang L., Dahl R.D., Kitada C., Kubo K., Fujino M., Minamino N., Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 170:1990;643-648.
13. Rindler M.J., Bashor M.M., Spitzer N., Saier M.H. Jr. Regulation of adenosine 3′,5′-monophosphate efflux from animal cells. J. Biol. Chem. 253:1978;5431-5436.
14. Ross-Ascuitto N.T., Ascuitto R.J., Ramage D., Kydon D.W., Coy D.H., Kadowitz P.J. Pituitary adenylate cyclase activating polypeptide: a neuropeptide with potent inotropic and coronary vasodilatory effects in neonatal pig hearts. Pediatr. Res. 34:1993;323-328.
15. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
16. Sreedharan S.P., Huang J.X., Cheung M.C., Goetzl E.J. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2939-2943.
17. Steiner A.L., Parker C.W., Kipnis D.M. Radioimmunoassay for cyclic nucleotides: I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem. 247:1972;1106-1113.
18. Suzuki Y., Kasai K., Takekoshi K., Oka M., Banba N., Numao T., Sugimura H., Iizuka M., Shimuda S.I. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system. Regul. Pept. 47:1993;213-220.
19. Wei Y., Mojsov S. Multiple human receptors for pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide are expressed in a tissue-specific manner. Ann. N. Y. Acad. Sci. 805:1996;624-627.
20. Yonezawa T., Furukawa Y., Lakhe M., Nagashima Y., Hirose M., Chiba S. PACAP-38 activates parasympathetic nerves in isolated, blood-perfused dog atria. Eur. J. Pharmacol. 315:1996;289-296.